Prostate Cancer Drug Candidate Developed at UTHSC Goes to First Clinical Trial

0
158
Drs. Duane Miller and Ramesh Narayanan, have developed a drug candidate for advanced metastatic prostate cancer that is in its first clinical trial and has received fast-track status from the US FDA, potentially accelerating its clinical development.
[The University of Tennessee Health Science Center]
Press Release